NASDAQ:RDHL

RedHill Biopharma - RDHL Earnings Date, Estimates & Call Transcripts

$0.96

-0.03 (-3.03%)

(As of 08/11/2022 12:00 AM ET)

Add

Compare

Today's Range: $0.96
▼
$1.01
50-Day Range: $0.63
▼
$1.07
52-Week Range: $0.62
▼
$11.18

Volume: 637,767 shs
Average Volume: 1.45 million shs
Market Capitalization: $50.58 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $17.67

Upcoming Earnings Date: Aug. 25Estimated
Actual EPS (Jun. 23): -$0.30 Beat By $0.10
Consensus EPS (Jun. 23): -$0.40
Last Year's Q2 EPS (5/26/2021): -$0.05

Read Call Transcript

Listen to Call

Earnings Per Share Revenue

RDHL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RDHL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

RedHill Biopharma Analyst Forecasts

Current Year EPS Consensus Estimate: $-0.95 EPS
Next Year EPS Consensus Estimate: $-0.35 EPS

RDHL Earnings Date and Information

RedHill Biopharma last posted its quarterly earnings results on June 23rd, 2022. The biotechnology company reported ($0.30) earnings per share for the quarter, beating the consensus estimate of ($0.40) by $0.10. The company earned $18.24 million during the quarter. RedHill Biopharma has generated ($1.88) earnings per share over the last year (($1.88) diluted earnings per share). Earnings for RedHill Biopharma are expected to grow in the coming year, from ($0.95) to ($0.35) per share. RedHill Biopharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 25th, 2022 based off prior year's report dates.

RedHill Biopharma Earnings History by Quarter

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
8/25/2022 (Estimated)
6/23/2022	Q1 2022	($0.40)	($0.30)	+$0.10	($0.30)		$18.24 million
3/17/2022	Q4 2021	($0.40)	($0.50)	($0.10)	($0.50)	$22.99 million	$22.07 million
11/30/2021	9/30/2021	($0.48)	($0.50)	($0.02)	($0.46)	$23.41 million	$21.61 million
8/25/2021	6/30/2021	($0.40)	($0.60)	($0.20)	($0.62)	$23.15 million	$21.50 million
5/26/2021	3/31/2021	($0.34)	($0.05)	+$0.29	($0.53)	$22.37 million	$20.58 million
3/17/2021	12/31/2020	($0.36)	($0.70)	($0.34)	($0.70)	$26.72 million	$21.46 million
11/17/2020	9/30/2020	($0.22)	($0.50)	($0.28)	($0.50)	$23.57 million	$20.94 million
8/13/2020	Q2 2020	($0.14)	($0.45)	($0.31)	($0.45)	$20.52 million	$20.90 million
5/27/2020	3/31/2020	($0.38)	($0.50)	($0.12)	($0.49)	$3.79 million	$1.06 million
3/4/2020	Q4 2019	($0.32)	($0.30)	+$0.02	($0.30)	$1.34 million	$1.59 million

11/19/2019	Q3 2019	($0.39)	($0.30)	+$0.09	($0.30)	$1.75 million	$1.40 million
7/23/2019	Q2 2019	($0.32)	($0.38)	($0.06)	($0.38)	$2.23 million	$1.56 million
5/7/2019	3/31/2019	($0.39)	($0.35)	+$0.04	($0.35)	$2.98 million	$1.74 million
2/26/2019	Q4 2018	($0.39)	($0.34)	+$0.05	($0.34)	$2.90 million	$1.36 million
11/13/2018	9/30/2018	($0.40)	($0.40)		($0.40)	$2.54 million	$2.21 million
8/30/2018	Q2 2018	($0.47)	($0.52)	($0.05)	($0.52)	$2.77 million	$2.35 million
5/8/2018	3/31/2018	($0.50)	($0.50)		($0.50)	$2.14 million	$2.45 million
2/22/2018	Q4 2017	($0.65)	($0.50)	+$0.15	($0.50)	$1.89 million	$2.00 million
11/13/2017	Q3 2017	($0.72)	($0.90)	($0.18)	($0.90)	$1.27 million	$1.52 million
7/25/2017	6/30/2017	($0.58)	($0.60)	($0.02)	($0.60)	$0.34 million	$0.48 million
5/3/2017	3/31/2017	($0.64)	($0.50)	+$0.14	($0.50)
2/23/2017	Q4 2016	($0.63)	($0.70)	($0.07)	($0.70)		$0.10 million
11/14/2016	Q3 2016	($0.59)	($0.70)	($0.11)	($0.70)
7/26/2016	Q2 2016	($0.61)	($0.60)	+$0.01	($0.60)
4/20/2016	Q1 2016	($0.48)	($0.43)	+$0.05	($0.43)
2/25/2016	Q4 2015	($0.47)	($0.50)	($0.03)	($0.50)	$0.05 million
11/9/2015	Q3 2015	($0.54)	($0.40)	+$0.14	($0.40)
7/29/2015	Q2 2015	($0.49)	($0.66)	($0.17)	($0.66)
4/30/2015	Q1 2015	($0.56)	($0.50)	+$0.06	($0.50)
2/26/2015	Q4 2014	($0.60)	($0.60)		($0.60)
11/10/2014	Q3 2014	($0.61)	($0.50)	+$0.11	($0.50)
7/23/2014	Q2 2014	($0.38)	($0.52)	($0.14)	($0.52)
6/6/2014		($0.44)	$0.39	+$0.83
4/30/2014	Q1 2014	($0.44)	$0.39	+$0.83	$0.39		$7.01 million
2/25/2014	Q4 2013	($0.50)	($0.50)		($0.50)
11/12/2013	Q3 2013	($0.62)	($0.43)	+$0.19	($0.43)
7/22/2013	Q2 2013	($0.44)	($0.40)	+$0.04	($0.40)
5/2/2013	Q1 2013	($0.45)	($0.30)	+$0.15	($0.30)
2/19/2013	Q4 2012	($0.44)	($0.70)	($0.26)	($0.70)

RedHill Biopharma Earnings - Frequently Asked Questions

When is RedHill Biopharma's earnings date?: RedHill Biopharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 25th, 2022 based off last year's report dates. Learn more on RDHL's earnings history.
Did RedHill Biopharma beat their earnings estimates last quarter?: In the previous quarter, RedHill Biopharma (NASDAQ:RDHL) reported ($0.30) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.40) by $0.10. Learn more on analysts' earnings estimate vs. RDHL's actual earnings.
How can I listen to RedHill Biopharma's earnings conference call?: The conference call for RedHill Biopharma's latest earnings report can be listened to online. Listen to Conference Call
How can I read RedHill Biopharma's conference call transcript?: The conference call transcript for RedHill Biopharma's latest earnings report can be read online. Read Transcript

How much revenue does RedHill Biopharma generate each year?: RedHill Biopharma (NASDAQ:RDHL) has a recorded annual revenue of $85.76 million.
How much profit does RedHill Biopharma generate each year?: RedHill Biopharma (NASDAQ:RDHL) has a recorded net income of -$97.74 million. RDHL has generated -$1.88 earnings per share over the last four quarters.
What is RedHill Biopharma's EPS forecast for next year?: RedHill Biopharma's earnings are expected to grow from ($0.95) per share to ($0.35) per share in the next year.

More Earnings Resources from MarketBeat

Earnings Tools:

Earnings By Country:

Latest Articles:

Upcoming Earnings:

BHP Group (8/16/2022)
Walmart (8/16/2022)
Home Depot (8/16/2022)
Cisco Systems (8/17/2022)
Analog Devices (8/17/2022)
Synopsys (8/17/2022)
TJX Companies (8/17/2022)
Target (8/17/2022)
Lowe's Companies (8/17/2022)
NetEase (8/18/2022)

This page (NASDAQ:RDHL) was last updated on 8/12/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources